The relaxant effect of nociceptin on porcine coronary arterial ring segments

被引:9
作者
Xu, PH
Chang, M
Cheng, LX
Cheng, Q
Yan, X
Wang, R
机构
[1] Lanzhou Univ, Sch Life Sci, Dept Biochem & Mol Biol, Lanzhou 730000, Peoples R China
[2] Lanzhou Med Coll, Affiliated Hosp 1, Lanzhou 730000, Peoples R China
关键词
nociceptin; porcine coronary artery; NO; ORL1;
D O I
10.1139/Y04-091
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nociceptin (NC), alias orphanin FQ, has been identified as the endogenous ligand of the opioid receptor-like 1 receptor (ORL1). The purpose of this study was to assess the effect of nociceptin on porcine coronary arteries and to investigate the mechanism of its action, if any. Rings of coronary arteries from porcine hearts were suspended in baths containing Krebs solution, and isometric tension was measured. The response to nociceptin (10(-12)-10(-5) mol/L) was investigated in porcine coronary arterial rings and also in such rings contracted with prostaglandin F-2alpha (PGF(2alpha)). The effects of endothelium, nitroxide (NO), methylene blue, cyclic GMP (cGMP), naloxone, [Nphe(1)]NC(1-13)NH2, and propranolol on nociceptin-induced relaxation were also assessed. Our study showed nociceptin relaxed the porcine coronary arterial rings and inhibited the vasocontractivity to PGF(2alpha). The relaxing response of nociceptin in coronary arteries was significantly reduced by removal of endothelium and by the presence of L-NNA, cGMP, and [Nphe(1)]NC(1-13)NH2, the selective nociceptin receptor antagonist, but not by naloxone, the nonselestive opioid receptor blocker or propranolol, which blocks the adrenergic P-receptor. Our results suggest that nociceptin induces relaxation of isolated coronary artery through NO, cGMP, and ORL1.
引用
收藏
页码:993 / 999
页数:7
相关论文
共 26 条
[1]   Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep [J].
Arndt, ML ;
Wu, DL ;
Soong, Y ;
Szeto, HH .
PEPTIDES, 1999, 20 (04) :465-470
[2]   Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies [J].
Bigoni, R ;
Giuliani, S ;
Calo, G ;
Rizzi, A ;
Guerrini, R ;
Salvadori, S ;
Regoli, D ;
Maggi, CA .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (03) :160-167
[3]   MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[4]  
CARTER DA, 1984, NEUROENDOCRINOL LETT, V6, P95
[5]   Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat [J].
Champion, HC ;
Czapla, A ;
Kadowitz, PJ .
PEPTIDES, 1997, 18 (05) :729-732
[6]   Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat [J].
Champion, HC ;
Pierce, RL ;
Kadowitz, PJ .
REGULATORY PEPTIDES, 1998, 78 (1-3) :69-74
[7]   Nociceptin, and endogenous ligand for the ORL(1) receptor, has novel hypotensive activity in the rat [J].
Champion, HC ;
Kadowitz, PJ .
LIFE SCIENCES, 1997, 60 (16) :PL241-PL245
[8]   Profound inhibition of cardiomotor neurons in the rat rostral ventrolateral medulla by nociceptin (orphanin FQ) [J].
Chu, XP ;
Xu, NS ;
Li, P ;
Wang, JQ .
NEUROREPORT, 1998, 9 (06) :1081-1084
[9]   Orphan receptors and their natural ligands [J].
Civelli, O ;
Nothacker, HP ;
Bourson, A ;
Ardati, A ;
Monsma, F ;
Reinscheid, R .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1997, 17 (1-3) :545-550
[10]   Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat [J].
Czapla, MA ;
Champion, HC ;
Kadowitz, PJ .
PEPTIDES, 1997, 18 (08) :1197-1200